Ameriprise
CDLX icon

Ameriprise’s Cardlytics CDLX Stock Holding History

Ameriprise’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,233
Closed -$22.4K – 3986
2025
Q1 		$22.4K Sell
1,233
-3
-0.2% -$86 ﹤0.01% 3979
2024
Q4 		$45.9K Sell
1,236
-150
-11% -$5.74K ﹤0.01% 4011
2024
Q3 		$44.3K Sell
1,386
-468
-25% -$26K ﹤0.01% 3886
2024
Q2 		$152K Sell
1,854
-2,751
-60% -$297K ﹤0.01% 3725
2024
Q1 		$667K Sell
4,605
-322
-7% -$27.2K ﹤0.01% 3321
2023
Q4 		$454K Buy
4,927
+893
+22% +$90.8K ﹤0.01% 3483
2023
Q3 		$666K Sell
4,034
-290
-7% -$37.7K ﹤0.01% 3306
2023
Q2 		$273K Sell
4,324
-225
-5% -$13.6K ﹤0.01% 3635
2023
Q1 		$154K Buy
4,549
+1,682
+59% +$87.9K ﹤0.01% 3777
2022
Q4 		$166K Buy
+2,867
New +$177K ﹤0.01% 3737
2022
Q3 		– Sell
-71,896
Closed -$16M – 3964
2022
Q2 		$16M Sell
71,896
-4,866
-6% -$1.63M 0.01% 1376
2022
Q1 		$42.2M Sell
76,762
-8,770
-10% -$5.3M 0.01% 883
2021
Q4 		$56.5M Buy
85,532
+48,611
+132% +$37.2M 0.02% 787
2021
Q3 		$30.9M Sell
36,921
-17,669
-32% -$17.9M 0.01% 981
2021
Q2 		$69.2M Sell
54,590
-1,126
-2% -$1.27M 0.02% 654
2021
Q1 		$61M Sell
55,716
-11,522
-17% -$15.2M 0.02% 695
2020
Q4 		$95.9M Sell
67,238
-1,124
-2% -$1.2M 0.03% 494
2020
Q3 		$48.2M Buy
68,362
+25,412
+59% +$18.5M 0.02% 656
2020
Q2 		$30M Sell
42,950
-10,780
-20% -$6.23M 0.01% 844
2020
Q1 		$18.8M Buy
+53,730
New +$38.1M 0.01% 974

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Ameriprise's CDLX Position: Q2 2025 in Review

Ameriprise sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,233 shares — an estimated $22.4K sold.

Ameriprise first reported a position in CDLX in Q1 2020 and held it in 20 quarters. The position peaked at $95.9M in Q4 2020. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Ameriprise reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 1,233 Cardlytics shares in Q2 2025, an estimated $22.4K.
  • Ameriprise first reported a position in Cardlytics in Q1 2020 and held it in 20 quarters.
  • Ameriprise's Cardlytics position peaked at $95.9M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.